BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
13.69
+2.15 (18.63%)
At close: Dec 5, 2025, 4:00 PM EST
13.75
+0.06 (0.44%)
After-hours: Dec 5, 2025, 7:48 PM EST
BBOT Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Cash & Equivalents | 408.74 | 30.85 | 0.25 |
| Short-Term Investments | 59.54 | 124.78 | - |
| Cash & Short-Term Investments | 468.29 | 155.63 | 0.25 |
| Cash Growth | 187214.00% | 62152.40% | - |
| Other Receivables | 0.23 | 0.08 | 1.72 |
| Receivables | 0.23 | 0.08 | 1.72 |
| Prepaid Expenses | 7.5 | 2.98 | 1.96 |
| Total Current Assets | 476.01 | 158.69 | 3.94 |
| Property, Plant & Equipment | 3.27 | 0.49 | 0.6 |
| Other Long-Term Assets | 5.52 | 5.12 | 1.41 |
| Accounts Payable | 3.65 | 3.07 | 0.58 |
| Accrued Expenses | 30.87 | 12.92 | 3.54 |
| Other Current Liabilities | 0.69 | 3.59 | 12.66 |
| Total Current Liabilities | 35.71 | 19.58 | 16.78 |
| Additional Paid-In Capital | 764.43 | 43.54 | 32.61 |
| Retained Earnings | -317.77 | -222.52 | -148.25 |
| Comprehensive Income & Other | 0.04 | 0.35 | - |
| Total Common Equity | 446.7 | -178.64 | -115.64 |
| Total Liabilities & Equity | 484.79 | 164.3 | 5.94 |
| Net Cash (Debt) | 465.4 | 155.63 | 0.25 |
| Net Cash Growth | 186059.20% | 62152.40% | - |
| Net Cash Per Share | 41.74 | 1072.39 | 2.00 |
| Filing Date Shares Outstanding | 79.99 | 0.32 | 0.12 |
| Total Common Shares Outstanding | 79.2 | 0.32 | 0.12 |
| Working Capital | 440.3 | 139.11 | -12.84 |
| Book Value Per Share | 5.64 | -558.92 | -927.16 |
| Tangible Book Value | 446.7 | -178.64 | -115.64 |
| Tangible Book Value Per Share | 5.64 | -558.92 | -927.16 |
Source: S&P Capital IQ. Standard template.
Financial Sources.